| PTGX Stock | | | USD 43.80 1.15 2.56% |
Protagonist Therapeutics financial indicator trend analysis is much more than just breaking down Protagonist Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Protagonist Therapeutics is a good investment. Please check the relationship between Protagonist Therapeutics Net Interest Income and its Other Operating Expenses accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in price.
For more information on how to buy Protagonist Stock please use our
How to Invest in Protagonist Therapeutics guide.
Net Interest Income vs Other Operating Expenses
Net Interest Income vs Other Operating Expenses Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Protagonist Therapeutics Net Interest Income account and
Other Operating Expenses. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Protagonist Therapeutics' Net Interest Income and Other Operating Expenses is 0.55. Overlapping area represents the amount of variation of Net Interest Income that can explain the historical movement of Other Operating Expenses in the same time period over historical financial statements of Protagonist Therapeutics, assuming nothing else is changed. The correlation between historical values of Protagonist Therapeutics' Net Interest Income and Other Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Interest Income of Protagonist Therapeutics are associated (or correlated) with its Other Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Operating Expenses has no effect on the direction of Net Interest Income i.e., Protagonist Therapeutics' Net Interest Income and Other Operating Expenses go up and down completely randomly.
Correlation Coefficient | 0.55 |
| Relationship Direction | Positive |
| Relationship Strength | Weak |
Net Interest Income
The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Protagonist Therapeutics. It is also known as Protagonist Therapeutics overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.
Most indicators from Protagonist Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Protagonist Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in price.
For more information on how to buy Protagonist Stock please use our
How to Invest in Protagonist Therapeutics guide.
Enterprise Value is likely to rise to about 1.2
B in 2024, whereas
Selling General Administrative is likely to drop slightly above 18
M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) |
Interest Income | 443K | 4.1M | 12.9M | 13.6M | Net Interest Income | 443K | 4.1M | 12.9M | 13.6M |
Protagonist Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Protagonist Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Protagonist Therapeutics fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to
measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.